1: (ROOT (S (NP (NML (NN Vitamin) (NNP D)) (NNS Levels)) (VP (VBP Appear) (TO To) (VP (VB Have) (NP (NP (DT A) (NN Role)) (PP (IN In) (NP (NP (CD COVI-19)) (PRP MortalityIt) (MD may) (VB be) (NP (DT a) (JJ good) (NN idea))))) (S (VP (TO to) (VP (VB spend) (NP (DT some) (NN time)) (PP (IN in) (NP (DT the) (NN sun))) (, ,) (PP (ADVP (RB especially)) (IN for) (NP (NP (NP (DT those)) (PP (IN with) (NP (VBG preexisting) (NNS conditions)))) (CC and) (NP (NP (DT those)) (ADJP (JJ worried) (PP (IN about) (NP (HYPH COVI-19))))))))))) (, ,) (SBAR (IN as) (S (NP (JJ recent) (NN research)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (NNS patients)) (PP (IN with) (NP (JJ severe) (NML (NN vitamin) (NN D)) (NN deficiency)))) (VP (VBP are) (ADJP (RB twice) (RB as) (JJ likely) (S (VP (TO to) (VP (VB experience) (NP (JJ major) (NNS complications))))))))))))) (. .)))
2: (ROOT (S (S (NP (NN Patient) (NNS data)) (VP (VBD was) (VP (VBN analyzed) (PP (IN from) (NP (CD 10) (NNS countries))) (SBAR (WHNP (WDT which)) (S (VP (VBD revealed) (NP (NP (DT a) (NN correlation)) (PP (IN between) (NP (NP (NP (JJ low) (NNS levels)) (PP (IN of) (NP (NN vitamin) (NNP D)))) (CC and) (NP (JJ hyperactive) (JJ immune) (NNS systems))))))))))) (: ;) (S (S (NP (NN vitamin) (NNP D)) (VP (VP (VBZ strengthens) (NP (JJ innate) (NN immunity))) (CC and) (VP (VBZ prevents) (NP (JJ overactive) (JJ immune) (NNS responses))))) (CC and) (S (NP (DT these) (NNS findings)) (VP (MD may) (VP (VB help) (S (VP (TO to) (VP (VB explain) (NP (NP (JJ several) (NNS mysteries)) (PP (VBG including) (SBAR (WHADVP (WRB why)) (S (NP (NNS children)) (VP (VBP are) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB die) (PP (IN from) (NP (DT this) (NN disease))))))))))))))))))) (. .)))
3: (ROOT (S (S (NP (NP (DT The) (NN research) (NN team)) (VP (VBN led) (PP (IN by) (NP (NNP Northwestern) (NNP University))))) (VP (VBD conducted) (NP (NP (DT a) (JJ statistical) (NN analysis)) (PP (IN of) (NP (NP (NNS data)) (PP (IN from) (NP (NP (NNS clinics) (CC and) (NNS hospitals)) (PP (IN across) (NP (NP (NNP America)) (, ,) (NP (NNP Spain)) (, ,) (NP (NNP Switzerland)) (, ,) (NP (NNP France)) (, ,) (NP (NP (NNP Germany)) (, ,) (NP (NNP Iran))) (, ,) (NP (NP (NNP Italy)) (, ,) (NP (NNP South) (NNP Korea))) (, ,) (NP (NNP China)) (, ,) (CC and) (NP (DT the) (NNP UK))))))))))) (: ;) (S (NP (NP (NNS patients)) (VP (VBG residing) (PP (IN in) (NP (NP (NNS countries)) (PP (IN with) (NP (JJ high) (NML (CD COVI-19)) (NN mortality) (NNS rates))))))) (VP (VBD were) (VP (VBN noted) (S (VP (TO to) (VP (VB have) (VP (VBD had) (NP (NP (JJR lower) (NNS levels)) (PP (IN of) (NP (NN vitamin) (NN D)))) (PP (VBN compared) (PP (IN to) (NP (NP (DT those)) (PP (IN in) (NP (NP (NNS countries)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (RB not) (ADJP (ADVP (RB as) (RB severely)) (VBN affected))))))))))))))))) (. .)))
4: (ROOT (SINV (`` `) (S (SBAR (IN While) (S (NP (PRP I)) (VP (VBP think) (SBAR (S (NP (NP (PRP it))) (VP (VBZ is) (ADJP (JJ important)) (SBAR (IN for) (S (NP (NNS people)) (VP (TO to) (VP (VB know) (SBAR (IN that) (S (NP (NML (NN vitamin) (NN D)) (NN deficiency)) (VP (MD might) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NN mortality))))))))))))))))) (, ,) (NP (PRP we)) (VP (VBP do) (`` ') (RB t) (VP (VB need) (S (VP (TO to) (VP (VB push) (NP (NN vitamin) (NN D)) (PP (IN on) (NP (NN everybody))))))))) (, ,) ('' ') (VP (VBD said)) (NP (NP (NP (NNP Northwestern) (POS 's)) (NNP Vadim) (NNP Backman)) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD led) (NP (DT the) (NN research)))))) (. .) ('' ')))
5: (ROOT (S (S (NP (DT This)) (VP (VBZ needs) (NP (JJ further) (NN study)))) (, ,) (CC and) (S (NP (PRP I)) (VP (VBP hope) (SBAR (S (NP (PRP$ our) (NN work)) (VP (MD will) (VP (VB stimulate) (NP (NP (NN interest)) (PP (IN in) (NP (DT this) (NN area)))))))))) (. .)))
6: (ROOT (S (NP (DT The) (NNS data)) (ADVP (RB also)) (VP (MD may) (VP (VB illuminate) (NP (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN mortality)))) (, ,) (SBAR (WHNP (WDT which)) (S (, ,) (SBAR (IN if) (S (VP (VBN proven)))) (, ,) (VP (MD could) (VP (VB lead) (PP (IN to) (NP (JJ new) (JJ therapeutic) (NNS targets)))))))))) (. .) ('' ')))
7: (ROOT (S (S (VP (VBN Inspired) (S (VP (TO to) (VP (VB examine) (NP (NP (DT the) (JJ unexplained) (NNS differences)) (PP (IN in) (NP (CD COVI-19) (NN mortality) (NNS rates)))) (PP (PP (IN from) (NP (NN country))) (PP (IN to) (NP (NN country)))) (PP (IN with) (NP (NP (DT some)) (VP (VBG suggesting) (SBAR (S (NP (PRP it)) (VP (VBD was) (PP (IN due) (IN to) (NP (NP (NN age) (NNS distributions)) (, ,) (NP (NN testing) (NNS rates)) (, ,) (NP (NP (JJ different) (NNS strains)) (PP (IN of) (NP (DT the) (NN virus)))) (, ,) (CC or) (NP (NP (NNS differences)) (PP (IN in) (NP (NN healthcare))))))))))))))))) (NP (DT the) (NN team)) (VP (VP (VBD remained) (ADJP (JJ skeptical) (PP (IN of) (NP (DT those) (NNS hypotheses))))) (CC and) (VP (VBD looked) (PP (IN for) (NP (DT a) (JJ common) (NN denominator))))) (. .)))
8: (ROOT (S ('' `) (S (NP (NP (NN None)) (PP (IN of) (NP (DT these) (NNS factors)))) (VP (VBZ appears) (S (VP (TO to) (VP (VB play) (NP (DT a) (JJ significant) (NN role))))))) (, ,) ('' ') (NP (NNP Backman)) (VP (VBD said)) (. .) ('' ')))
9: (ROOT (S (NP (NP (DT The) (NN healthcare) (NN system)) (PP (IN in) (NP (JJ northern) (NNP Italy)))) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJS best)) (PP (IN in) (NP (DT the) (NN world))))))) (. .)))
10: (ROOT (S (NP (NP (NNS Differences)) (PP (IN in) (NP (NN mortality)))) (VP (VBP exist) (SBAR (ADVP (RB even)) (IN if) (S (NP (PRP one)) (VP (VBZ looks) (PP (IN across) (NP (DT the) (JJ same) (NN age) (NN group))))))) (. .)))
11: (ROOT (S (CC And) (, ,) (SBAR (IN while) (S (NP (NP (DT the) (NNS restrictions)) (PP (IN on) (NP (NN testing)))) (VP (VBP do) (ADVP (RB indeed)) (VP (VBP vary))))) (, ,) (NP (NP (DT the) (NNS disparities)) (PP (IN in) (NP (NN mortality)))) (ADVP (RB still)) (VP (VBP exist) (SBAR (WHADVP (RB even) (WRB when)) (S (NP (PRP we)) (VP (VBD looked) (PP (IN at) (NP (NP (NNS countries) (CC or) (NNS populations)) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (JJ similar) (NN testing) (NNS rates)) (VP (VBP apply)))))))))) (. .) ('' ') ('' ')))
12: (ROOT (S (ADVP (RB Instead)) (, ,) (NP (PRP we)) (VP (VBD saw) (NP (NP (DT a) (JJ significant) (NN correlation)) (PP (IN with) (NP (NML (NN vitamin) (NN D)) (NN deficiency))))) (. .) ('' ')))
13: (ROOT (S (S (VP (VBG Analyzing) (NP (NP (ADJP (RB publicly) (JJ available)) (NN patient) (NNS data)) (PP (IN from) (NP (NP (DT the) (JJ various) (NNS countries)) (PP (IN around) (NP (DT the) (NN globe)))))))) (VP (VBD allowed) (S (NP (DT the) (NN team)) (VP (TO to) (VP (VB discover) (NP (NP (NP (DT the) (JJ strong) (NN correlation)) (PP (IN between) (NP (NP (NML (NN vitamin) (NN D)) (NNS levels)) (CC and) (NP (NP (DT the) (NN cytokine) (NN storm)) (VP (VBN caused) (PP (IN by) (NP (DT the) (JJ overactive) (JJ immune) (NN system)))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT a) (NN correlation)) (PP (IN between) (NP (NP (NML (NN vitamin) (NNP D)) (NN deficiency)) (CC and) (NP (DT the) (VBN increased) (NN mortality) (NN rate)))))))))) (. .)))
14: (ROOT (SINV (`` `) (S (NP (NN Cytokine) (NN storm)) (VP (VP (MD can) (ADVP (RB severely)) (VP (VB damage) (NP (NNS lungs)))) (CC and) (VP (VB lead) (PP (IN to) (NP (NP (JJ acute) (NML (JJ respiratory) (NN distress)) (NN syndrome)) (CC and) (NP (NN death)))) (PP (IN in) (NP (NNS patients)))))) (, ,) ('' ') (VP (VBD said)) (NP (NML (JJ first) (NN author)) (NNP Ali) (NNP Daneshkhah)) (. .) ('' ')))
15: (ROOT (S (NP (DT This)) (VP (VBZ is) (SBAR (WHNP (WP what)) (S (VP (VBZ seems) (S (VP (TO to) (VP (VP (VB kill) (NP (NP (DT a) (NN majority)) (PP (IN of) (NP (HYPH COVI-19) (NNS patients))))) (, ,) (RB not) (NP (NP (DT the) (NN destruction)) (PP (IN of) (NP (DT the) (NNS lungs))) (PP (IN by) (NP (NP (DT the) (NN virus)) (NP (PRP itself)))))))))))) (. .)))
16: (ROOT (S (NP (PRP It)) (VP (VBZ is) (NP (NP (DT the) (NNS complications)) (PP (IN from) (NP (NP (DT the) (VBN misdirected) (NN fire)) (PP (IN from) (NP (DT the) (JJ immune) (NN system))))))) (. .) ('' ')))
17: (ROOT (S (NP (DT This)) (VP (VBZ is) (SBAR (SBAR (WHADVP (WRB where)) (S (NP (NN vitamin) (NNP D)) (VBZ is) (VBN believed) (S (VP (TO to) (VP (VB play) (NP (DT a) (JJ key) (NN role))))))) (, ,) (SBAR (IN as) (S (CONJP (RB not) (RB only)) (SINV (VBZ does) (NP (PRP it)) (VP (VB boost) (NP (DT the) (JJ innate) (JJ immune) (NNS systems)))) (, ,) (S (NP (PRP it)) (ADVP (RB also)) (VP (VBZ prevents) (NP (DT the) (JJ immune) (NN system)) (PP (IN from) (S (VP (VBG becoming) (ADJP (RB dangerously) (RB over) (JJ active))))))) (: ;) (S (VP (VBG meaning) (SBAR (IN that) (S (S (VP (VBG maintaining) (NP (NP (JJ healthy) (NNS levels)) (PP (IN of) (NP (NN vitamin) (NNP D)))))) (VP (MD could) (VP (VB protect) (NP (NNS patients)) (PP (IN from) (NP (NP (JJ severe) (NNS complications)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB include) (NP (NP (NN death)) (PP (IN from) (NP (CD COVI-19)))))))))))))))))))) (. .)))
18: (ROOT (S ('' `) (S (NP (PRP$ Our) (NN analysis)) (VP (VBZ shows) (SBAR (IN that) (S (NP (PRP it)) (VP (MD might) (VP (VB be) (ADJP (ADJP (RB as) (JJ high)) (PP (IN as) (S (VP (VBG cutting) (NP (DT the) (NN mortality) (NN rate)) (PP (IN in) (NP (DT half))))))))))))) (, ,) ('' ') (NP (NNP Backman)) (VP (VBD said)) (. .) ('' ')))
19: (ROOT (S (S (NP (PRP It)) (VP (MD will) (RB not) (VP (VB prevent) (NP (DT a) (NN patient)) (PP (IN from) (S (VP (VBG contracting) (NP (DT the) (NN virus)))))))) (, ,) (CC but) (S (NP (PRP it)) (VP (MD may) (VP (VP (VB reduce) (NP (NNS complications))) (CC and) (VP (VB prevent) (NP (NN death)) (PP (IN in) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBN infected))))))))))) (. .) ('' ')))
20: (ROOT (S (NP (DT This) (NN correlation)) (VP (MD may) (VP (VB explain) (SBAR (WHADVP (WRB why)) (S (NP (NNS childrens)) (VP (VBP are) (ADJP (RBR less) (JJ likely) (S (VP (TO to) (VP (VB die) (PP (IN from) (NP (DT this) (NN disease))))))) (, ,) (SBAR (IN as) (S (NP (PRP they)) (VP (VBP do) (`` ') (RB t) (VP (VB have) (NP (NP (DT a) (ADJP (RB fully) (VBN developed)) (VBN acquired) (JJ immune) (NN system)) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ is) (NP (NP (NP (DT the) (JJ immune) (NN system) (POS 's)) (JJ second) (NN line)) (PP (IN of) (NP (NN defense))))) (CC and) (VP (VBZ is) (ADJP (RBR more) (JJ likely) (S (VP (TO to) (VP (VB overreact))))))))))))))))))) (. .) ('' ')))
21: (ROOT (S (S (NP (NNS Children)) (ADVP (RB primarily)) (VP (VBP rely) (PP (IN on) (NP (PRP$ their) (JJ innate) (JJ immune) (NN system))))) (, ,) ('' ') (NP (NNP Backman)) (VP (VBD said)) (. .) ('' ')))
22: (ROOT (S (NP (DT This)) (VP (MD may) (VP (VB explain) (SBAR (WHADVP (WRB why)) (S (NP (PRP$ their) (NN mortality) (NN rate)) (VP (VBZ is) (ADJP (JJR lower))))))) (. .) ('' ')))
23: (ROOT (S (NP (DT The) (NNS researchers)) (VP (VBP caution) (SBAR (IN that) (S (NP (DT this)) (VP (VBZ does) (RB not) (VP (VB mean) (SBAR (IN that) (S (NP (NN everyone)) (VP (VBZ needs) (S (VP (TO to) (VP (VB start) (S (VP (VBG hoarding) (NP (NML (NN vitamin) (NNP D)) (NNS supplements))))))) (, ,) (NP (NP (ADVP (RB especially)) (NP (DT those))) (PP (IN without) (NP (DT a) (VBN known) (NN deficiency)))))))))))) (. .)))
24: (ROOT (S (NP (NP (DT All)) (SBAR (S (NP (PRP one)) (VP (VBZ needs) (S (VP (S (VP (TO to) (VP (VB do)))) (S (VP (TO to) (VP (VB boost) (NP (NML (NN vitamin) (NN D)) (NNS levels))))))))))) (VP (VBZ is) (S (VP (TO to) (VP (VB spend) (NP (NP (QP (RB about) (CD 10) (IN to) (CD 30)) (NNS minutes)) (NP (DT a) (NN day))) (PP (IN in) (NP (JJ direct) (NN sunlight))) (NP (NP (DT a) (JJ few) (NNS times)) (PP (IN per) (NP (NN week)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ free))))))))) (. .)))
25: (ROOT (S (ADVP (RB Also)) (NP (NP (PRP it))) (VP (VBZ is) (ADJP (JJ important)) (S (RB not) (VP (TO to) (VP (VB take) (NP (NP (NP (JJ excessive) (NNS doses)) (PP (IN of) (NP (NML (NN vitamin) (NN D)) (NNS supplements)))) (SBAR (WHNP (WDT which)) (S (VP (MD could) (VP (VB have) (NP (DT some) (JJ negative) (JJ side) (NNS effects))))))))))) (. .)))
26: (ROOT (S (NP (NNP Backman)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (JJR more) (NN research)) (VP (VBZ is) (VP (VBN required) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (JJ protective) (NNS effects)) (PP (IN of) (NP (NN vitamin) (NNP D))) (PP (IN against) (NP (CD COVI-19)))))))))))) (. .)))
27: (ROOT (S (`` `) (S (NP (NP (PRP It))) (VP (VBZ is) (ADJP (JJ hard)) (S (VP (TO to) (VP (VB say) (SBAR (WHNP (WDT which) (NN dose)) (S (VP (VBZ is) (ADJP (RBS most) (JJ beneficial) (PP (IN for) (NP (CD COVI-19)))))))))))) (, ,) ('' ') (NP (NNP Backman)) (VP (VBD said)) (. .) ('' ')))
28: (ROOT (S (ADVP (RB However)) (, ,) (S (NP (NP (PRP it))) (VP (VBZ is) (ADJP (JJ clear)) (SBAR (IN that) (S (NP (NML (NN vitamin) (NNP D)) (NN deficiency)) (VP (VBZ is) (ADJP (JJ harmful))))))) (, ,) (CC and) (S (NP (PRP it)) (VP (MD can) (VP (VB be) (ADVP (RB easily)) (VP (VBN addressed) (PP (IN with) (NP (JJ appropriate) (NN supplementation))))))) (. .)))
29: (ROOT (S (NP (DT This)) (VP (MD might) (VP (VB be) (NP (NP (DT another) (NN key)) (PP (IN to) (S (VP (VBG helping) (S (VP (VB protect) (NP (NP (JJ vulnerable) (NNS populations)) (, ,) (PP (JJ such) (IN as) (NP (NP (ADJP (ADJP (NNP Africa) (HYPH -) (JJ American)) (CC and) (ADJP (JJ elderly))) (NNS patients)) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBP have) (NP (NP (DT a) (NN prevalence)) (PP (IN of) (NP (NML (NN vitamin) (NN D)) (NN deficiency)))))))))))))))))) (. .) ('' ')))
